Singapore
Its developer, a spinoff from Nanyang Technological University, Singapore, is looking to raise up to $1.5 million to commercialise their MCI screening tool.
Also, Aevice Health from Singapore has obtained new investment for its global expansion.
The analytical tool can also predict demographics and understand personality traits by understanding brain activity patterns.
A Singaporean startup is set to introduce its doctor companion AI across Australia and Southeast Asia starting this year.
A Singaporean startup leverages Asian-specific databases in making heart disease risk assessments.